ebomi
Colour theme
Sign in
Insider · CIK 0001374150

Domain Parters VII L P

CIK 0001374150 Name as filed on the most recent filing

Filed as Domain Parters VII L P (50)

79 transaction lines · from 50 filings · filed 2008-12-11 to 2019-08-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-01-30 S, Open-market sale Cadence Pharmaceuticals IncCADX 55,525, disposed Open Form 4 filing 0000904454-13-000152
2013-01-29 S, Open-market sale Cadence Pharmaceuticals IncCADX 80,736, disposed Open Form 4 filing 0000904454-13-000140
2013-01-28 S, Open-market sale Cadence Pharmaceuticals IncCADX 89,964, disposed Open Form 4 filing 0000904454-13-000140
2013-01-25 S, Open-market sale Cadence Pharmaceuticals IncCADX 74,190, disposed Open Form 4 filing 0000904454-13-000126
2013-01-24 S, Open-market sale Cadence Pharmaceuticals IncCADX 197,966, disposed Open Form 4 filing 0000904454-13-000126
2013-01-23 S, Open-market sale Cadence Pharmaceuticals IncCADX 129,559, disposed Open Form 4 filing 0000904454-13-000080
2013-01-22 S, Open-market sale Cadence Pharmaceuticals IncCADX 75,129, disposed Open Form 4 filing 0000904454-13-000080
2013-01-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 99,025, disposed Open Form 4 filing 0000904454-13-000066
2013-01-17 S, Open-market sale Cadence Pharmaceuticals IncCADX 67,490, disposed Open Form 4 filing 0000904454-13-000066
2011-12-22 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 668,834, acquired Open Form 4 filing 0000904454-11-000677
2011-11-21 P, Open-market purchase Clovis Oncology, Inc.CLVS 11,908,754, acquired Open Form 4 filing 0000904454-11-000619
2011-09-16 P, Open-market purchase Zogenix, Inc.ZGNX 6,882,608, acquired Open Form 4 filing 0000904454-11-000535
2010-11-29 P, Open-market purchase Zogenix, Inc.ZGNX 9,242,356, acquired Open Form 4 filing 0000904454-10-000473
2009-12-18 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 280,958, acquired Open Form 4 filing 0000904454-09-000810
2009-12-17 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 742,339, acquired Open Form 4 filing 0000904454-09-000810
2009-11-24 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 331,837, acquired Open Form 4 filing 0000904454-09-000742
2009-11-23 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 1,022,064, acquired Open Form 4 filing 0000904454-09-000720
2009-11-20 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 1,703,449, acquired Open Form 4 filing 0000904454-09-000720
2009-11-12 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 420,624, acquired Open Form 4 filing 0000904454-09-000694
2009-11-11 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 365,218, acquired Open Form 4 filing 0000904454-09-000676
2009-11-10 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 575,086, acquired Open Form 4 filing 0000904454-09-000676
2009-08-18 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 104,765, acquired Open Form 4 filing 0000904454-09-000347
2009-08-17 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 474,757, acquired Open Form 4 filing 0000904454-09-000337
2009-08-14 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 206,280, acquired Open Form 4 filing 0000904454-09-000337
2009-08-13 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 100,339, acquired Open Form 4 filing 0000904454-09-000321
2009-08-12 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 3,146,336, acquired Open Form 4 filing 0000904454-09-000321
2009-08-11 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 779,388, acquired Open Form 4 filing 0000904454-09-000290
2009-07-23 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 4,793,243, acquired Open Form 4 filing 0000904454-09-000272
2008-12-09 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 1,172,482, acquired Open Form 4 filing 0000904454-08-000487

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DOMAIN PARTERS VII L P, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001374150

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.